Prevalence and Risk Factors for VRE Colonisation in a Tertiary Hospital in Melbourne, Australia: a Cross Sectional Study
Overview
Authors
Affiliations
Unlabelled:
Background: Vancomycin-resistant Enterococcus (VRE) has been established as a significant health-care associated problem since its first isolation in Australia in 1994. In this study, we measured the point prevalence and identified risk factors associated with vanB VRE colonisation in a tertiary care hospital in Melbourne, Australia where VRE has been endemic for 15 years.
Methods: A hospital-wide point prevalence survey was conducted on October 13, 2008 with colonisation detected using rectal swab culture. Patient's demographic and medical information was collected through a review of medical records. Factors associated with VRE colonisation in univariate analysis were included in multivariate logistic regression model to adjust for confounding.
Results: The prevalence of VRE colonisation on the day of screening was 17.5% (95% CI, 13.7 to 21.9). VRE was detected from patients in each ward with the prevalence ranging from 3% to 29%. Univariate analysis showed the use of any antibiotic, meropenem, ciprofloxacin, diarrhoea and longer length of hospital stay were associated with increased risk of VRE colonisation (p<0.05). However, age, sex, proximity to VRE positive cases, use of other antibiotics including cephalosporins, vancomycin were not associated with increased risk (P>0.05). Multivariate analysis showed the exposure to meropenem (p=0.004), age (≥65 years) (p=0.036) and length of stay ≥7 days (p<0.001) as independent predictors of VRE colonisation.
Conclusion: Our study suggests that exposure to antibiotics may have been more important than recent cross transmission for a high prevalence of vanB VRE colonisation at our hospital.
El Haddad L, Angelidakis G, Zhai Y, Yaghi L, Arias C, Shelburne S Microorganisms. 2024; 12(8).
PMID: 39203518 PMC: 11356748. DOI: 10.3390/microorganisms12081676.
Founou R, Founou L, Allam M, Ismail A, Essack S BMC Infect Dis. 2024; 24(1):671.
PMID: 38965470 PMC: 11225414. DOI: 10.1186/s12879-024-09380-3.
Shirvani F, Hassanzadeh R, Attaran B, Ghandchi G, Abdollahi N, Gholinejad Z BMC Pediatr. 2023; 23(1):434.
PMID: 37648974 PMC: 10466818. DOI: 10.1186/s12887-023-04238-0.
MacKenzie P, Farber J, Post M, Esser T, Bechmann L, Kropf S BMC Infect Dis. 2023; 23(1):274.
PMID: 37131139 PMC: 10155433. DOI: 10.1186/s12879-023-08238-4.
Ling C, Sud K, Peterson G, Fethney J, Van C, Patel R J Nephrol. 2023; 36(7):1877-1888.
PMID: 36913080 PMC: 10543707. DOI: 10.1007/s40620-023-01597-w.